• Source: BERICAP Holding GmbH. Copyright Foto Vogt GmbH.
    Source: BERICAP Holding GmbH. Copyright Foto Vogt GmbH.
Close×

One of the world’s leading plastic closure manufacturers has teamed up with NFC supplier Thinfilm to embed chips into its caps worldwide.

Thinfilm, a member of the Active and Intelligent Packaging Industry Association (AIPIA), will provide Bericap with NFC chips for brand protection and authentication of over-the-counter pharmaceuticals and industrial products.

“This partnership with Thinfilm allows us to offer another important security and marketing tool for our customers in a range of markets,” said Jörg Thiels, Chief Executive Officer of Bericap Industrial Products. “Smart and anti-counterfeiting packaging solutions are fast developing requirements and Thinfilm’s technology and software platform is a perfect fit to further extend Bericap's extensive assortment of closures.”

According to Kevin Barber, CEO of Thinfilm, Bericap represents an important strategic partner, and the integration of NFC into injection-moulded closures will allow consumers to easily interact with products; ensure authenticity; and provide valuable data to brands.

“Fake products are not only a menace but also a safety risk and a danger to a brand’s reputation and its consumer relationships. We are looking forward to joining forces in developing product closure solutions that will help thwart the global problem of counterfeiting, refill fraud, tampering, and diversion.

“These solutions will add differentiation, interactivity, and relevance to Bericap’s current customer offering,” he said.

Bericap manufactures more than 84 billion plastic closures per year.

Food & Drink Business

A coalition of global food waste organisations has called on the COP31 presidency to turn existing commitments on food loss and waste into funded policy. It’s a move with direct relevance to Australia, which holds the presidency of negotiations for this year’s climate summit.

Inghams has placed its Western Australian farms and processing operations into complete lockdown after authorities confirmed Australia’s first detection of the high pathogenicity H5 avian influenza strain that has spread globally since 2020.

The a2 Milk Company is set to return $300 million to shareholders after securing Chinese regulatory approval that finalises its acquisition of the a2 Pokeno infant formula facility in New Zealand.